These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20017657)

  • 61. Strategic trends of pharmaceutical companies: A growth model through regional focus and inter-regional alliances.
    Nakashima A; Kodama K; Sengoku S
    Drug Discov Today; 2023 Jul; 28(7):103611. PubMed ID: 37164307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Funding translational work in cell-based therapy.
    Rao MS
    Cell Stem Cell; 2011 Jul; 9(1):7-10. PubMed ID: 21726828
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Deregulation: causes and consequences.
    Bailey EE
    Science; 1986 Dec; 234(4781):1211-6. PubMed ID: 17778003
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of solvent selection at exploratory and production stages in the pharmaceutical industry.
    Nicponski DR; Ramachandran PV
    Future Med Chem; 2011 Sep; 3(12):1469-73. PubMed ID: 21882940
    [No Abstract]   [Full Text] [Related]  

  • 65. Drug Discovery and Development Asia-Pacific Conference 2005. Strategies and case studies of successful alliances, licensing and outsourcing partnerships.
    Alger L
    IDrugs; 2005 Aug; 8(8):639-41. PubMed ID: 16044371
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mission control: Drug developers test the 'benefit corporation' business model.
    Frood A
    Nat Med; 2017 Oct; 23(10):1117-1118. PubMed ID: 28985208
    [No Abstract]   [Full Text] [Related]  

  • 67. Most profitable U.S. drug and biologic companies. Ranked by 2013 profit margin.
    Mod Healthc; 2014 Dec; Suppl():30. PubMed ID: 25831880
    [No Abstract]   [Full Text] [Related]  

  • 68. The role of chemical engineering in pharmaceutical chemical process development.
    Landau RN; Blacklock TJ; Girgis MJ; Tedesco A
    Curr Opin Drug Discov Devel; 1998 Nov; 1(3):257-63. PubMed ID: 19649800
    [TBL] [Abstract][Full Text] [Related]  

  • 69. When Is an In Silico Representation a Digital Twin? A Biopharmaceutical Industry Approach to the Digital Twin Concept.
    Portela RMC; Varsakelis C; Richelle A; Giannelos N; Pence J; Dessoy S; von Stosch M
    Adv Biochem Eng Biotechnol; 2021; 176():35-55. PubMed ID: 32797270
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Integrative knowledge management to enhance pharmaceutical R&D.
    Marti-Solano M; Birney E; Bril A; Della Pasqua O; Kitano H; Mons B; Xenarios I; Sanz F
    Nat Rev Drug Discov; 2014 Apr; 13(4):239-40. PubMed ID: 24687050
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term pharmaceutical industry alliance formed in Japan.
    Hill R
    Future Med Chem; 2013 Jul; 5(11):1191. PubMed ID: 24020084
    [No Abstract]   [Full Text] [Related]  

  • 72. Revving up the immune therapy business.
    Cancer Discov; 2015 Aug; 5(8):789. PubMed ID: 26134049
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug companies maintain "astounding" profits.
    Gottlieb S
    BMJ; 2002 May; 324(7345):1054. PubMed ID: 11993483
    [No Abstract]   [Full Text] [Related]  

  • 74. Innovative pharmaceutical technologies. Preface.
    Rossi C
    Int J Pharm; 2013 Jan; 440(2):125. PubMed ID: 23064127
    [No Abstract]   [Full Text] [Related]  

  • 75. AOA Critical Issues Symposium: I Have an Idea…Now What?
    Suk M; Friedman LGM; Antoniou J; Cochrane S
    J Bone Joint Surg Am; 2022 Dec; 104(24):e104. PubMed ID: 36054368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies.
    Ledley FD; McNamee LM; Uzdil V; Morgan IW
    Gene Ther; 2014 Feb; 21(2):188-94. PubMed ID: 24305420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hybridization of the Kano model and business model canvas: aeronautical and metalworking industry in Bogota, Colombia.
    Montenegro JF; Contreras PA; Sáenz F
    Heliyon; 2021 Oct; 7(10):e08097. PubMed ID: 34646955
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transformation in the pharmaceutical industry--a systematic review of the literature.
    Shafiei N; Ford JL; Morecroft CW; Lisboa PJ; Taylor MJ; Mouzughi Y
    PDA J Pharm Sci Technol; 2013; 67(2):105-22. PubMed ID: 23569072
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Strategic use of statistical thinking in drug development.
    Rockhold FW
    Stat Med; 2000 Dec; 19(23):3211-7. PubMed ID: 11113955
    [TBL] [Abstract][Full Text] [Related]  

  • 80. What Drives Innovation: The Canadian Touch on Liposomal Therapeutics.
    Leung AWY; Amador C; Wang LC; Mody UV; Bally MB
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30884782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.